Management of palatal myoclonic tinnitus based on clinical characteristics: a large case series study

  title={Management of palatal myoclonic tinnitus based on clinical characteristics: a large case series study},
  author={Jung Mee Park and Woo Jin Kim and Jae Sang Han and So Young Park and Shi-Nae Park},
  journal={Acta Oto-Laryngologica},
  pages={553 - 557}
  • Jung Mee Park, Woo Jin Kim, +2 authors Shi-Nae Park
  • Published 14 May 2020
  • Medicine
  • Acta Oto-Laryngologica
Abstract Background: Palatal myoclonic tinnitus (PMT) is a rare otological condition caused by rhythmic contractions of soft palate muscles. Due to its rarity, only a few case series studies have been reported in the literature at the present time. Aims: This large case series study reviews treatment outcomes of PMT patients over the past 15 years based on clinical characteristics. Materials and methods: Between the year 2003 and 2018, 54 patients with a diagnosis of PMT were assessed. Clinical… 


Objective tinnitus associated with essential palatal myoclonus: report in a child.
The case of a 7-year-old girl with bilateral objective tinnitus due to palatal myoclonus without hearing impairment but with otherwise normal hearing thresholds and no evidence of intracerebral or systemic disorders is presented.
Symptomatic and essential rhythmic palatal myoclonus.
The rhythmicity of RPM seems to be more profoundly influenced by sleep, coma and general anaesthesia in essential than in symptomatic RPM, which means that essential RPM should be separated as a distinct clinical entity.
Clinical characteristics and therapeutic response of objective tinnitus due to middle ear myoclonus: A large case series
To evaluate the clinical characteristics and therapeutic response of tinnitus due to middle ear myoclonus (MEM) and to suggest appropriate diagnostic methods.
Analysis of the Prevalence and Associated Risk Factors of Tinnitus in Adults
Tinnitus is very common in the general population and is associated with gender, smoking, stress, sleep, hearing loss, hyperlipidemia, osteoarthritis, rheumatoid arthritis, asthma, depression, and thyroid disease history.
Palatal myoclonus: Algorithm for management with botulinum toxin based on clinical disease characteristics
To review the clinical characteristics and management of patients with palatal myoclonus and devise an algorithm for treatment with botulinum toxin based on presenting symptoms, clinical examination
Myoclonus: Pathophysiology and Treatment Options
Deep brain stimulation targeting the globus pallidus pars-interna bilaterally has been used in myoclonus-dystonia when pharmacological treatments have been exhausted.
Clinical application of botulinum toxin in otolaryngology, head and neck practice (brief review).
  • S. Yin, F. Stucker, C. Nathan
  • Medicine
    The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society
  • 2001
The literature is reviewed and experiences with Botox are described, including such topics as preparing and storing Botox, identifying the target muscles under EMG-guidance, choosing an appropriate dose, and outlining the applications of Botox in Otolaryngology, Head and Neck Surgery practice.
Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia
The data suggest that botulinum toxin can transiently alter the excitability of the cortical motor areas by reorganizing the inhibitory and excitatory intracortical circuits.
Inhibition of forearm EMG by palatal myoclonus
  • R. Elble
  • Medicine
    Movement disorders : official journal of the Movement Disorder Society
  • 1991
The forearm electromyogram, pharyngeal EMG, and wrist tremor were recorded simultaneously from a 74‐year‐old woman with the syndrome of palatal myoclonus and progressive ataxia to support the notion that rhythmic olivocerebellar discharges can cause tremorogenic excitation and inhibition of postural EMG activity in the upper extremities.
Botulinum Toxin Use in the Upper Face.
  • Clement Qaqish
  • Medicine
    Atlas of the oral and maxillofacial surgery clinics of North America
  • 2016
Botulinum toxin is a potent exotoxin that disrupts neuromuscular transmission by inhibiting the release for acetylcholine from the presynaptic membrane resulting in attenuation of muscle contraction.